These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


305 related items for PubMed ID: 30676715

  • 1. Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease.
    Wu X, Meng X, Tan F, Jiao Z, Zhang X, Tong H, He X, Luo X, Xu P, Qu S.
    ACS Chem Neurosci; 2019 Mar 20; 10(3):1791-1800. PubMed ID: 30676715
    [Abstract] [Full Text] [Related]

  • 2. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2 via miR-221-3p binding.
    Lang Y, Li Y, Yu H, Lin L, Chen X, Wang S, Zhang H.
    Aging (Albany NY); 2020 May 12; 12(9):7660-7678. PubMed ID: 32396526
    [Abstract] [Full Text] [Related]

  • 3. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
    Tao X, Zhang W, Chen C, Tao Y, Tao Y, Chen Z, Zhang G.
    Aging (Albany NY); 2024 May 21; 16(10):8732-8746. PubMed ID: 38775730
    [Abstract] [Full Text] [Related]

  • 4. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
    Zhang Y, Meng X, Jiao Z, Liu Y, Zhang X, Qu S.
    ACS Chem Neurosci; 2020 Feb 05; 11(3):406-417. PubMed ID: 31909584
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N, Beiping H, Dheen ST, Tay SS.
    Neuroscience; 2014 Jul 11; 272():167-79. PubMed ID: 24792712
    [Abstract] [Full Text] [Related]

  • 6. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.
    Wu DM, Wang S, Wen X, Han XR, Wang YJ, Shen M, Fan SH, Zhuang J, Zhang ZF, Shan Q, Li MQ, Hu B, Sun CH, Lu J, Chen GQ, Zheng YL.
    J Cell Physiol; 2019 Jun 11; 234(6):9033-9044. PubMed ID: 30362546
    [Abstract] [Full Text] [Related]

  • 7. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
    Su C, Yang X, Lou J.
    Brain Res; 2016 Aug 01; 1644():98-106. PubMed ID: 27173998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Direct α-synuclein promoter transactivation by the tumor suppressor p53.
    Duplan E, Giordano C, Checler F, Alves da Costa C.
    Mol Neurodegener; 2016 Feb 02; 11():13. PubMed ID: 26833254
    [Abstract] [Full Text] [Related]

  • 12. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
    Zhou S, Zhou X, Jiang Z, Ma J, Li Y, Qian Z, Li H.
    Neurochem Res; 2023 Mar 02; 48(3):942-955. PubMed ID: 36401052
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
    Esteves M, Cristóvão AC, Vale A, Machado-Pereira M, Ferreira R, Bernardino L.
    Neurochem Res; 2024 Jul 02; 49(7):1677-1686. PubMed ID: 38451434
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
    Li D, Yang H, Ma J, Luo S, Chen S, Gu Q.
    Hum Cell; 2018 Apr 02; 31(2):106-115. PubMed ID: 29274035
    [Abstract] [Full Text] [Related]

  • 15. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R, Cunha-Oliveira T, Rego AC.
    Free Radic Biol Med; 2013 Sep 02; 62():186-201. PubMed ID: 23743292
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.